Professional Documents
Culture Documents
Practical Outline With Solutions
Practical Outline With Solutions
Practical Outline With Solutions
This practice session focuses on applying some of the theoretical work covered in previous
courses. The questions asked here closely resemble the exam questions, although the exam
will be supplemented with questions that involve correctly interpreting course material for a
practical application. If you understand the questions in this practical, this should be no
problem.
The use of ChatGPT is absolutely prohibited during the exam!
In this practical session, we will run through two separate cases. Each case involves a
specific protein, and several point mutations in that protein.
Sidenote: obviously the answers above are very crude estimations based on the residues'
general properties. Of course, even if properties are similar overall, it is still possible small
differences have large structural consequences, which is very dependent on the structural
context. In this exercise, we simply want you to consider general amino acid properties and
compare these.
Topic 2: Uniprot
If the protein has more than one isoform, answer the questions using the canonical one!
Case 1:
Protein X GTPase HRas
UniProt identifier P01112
Residues A, B, C and D A59, K5, L52, F78
Mutation M Q61L
Case 2:
Protein X Signal transducer and activator of transcription 3
UniProt identifier P40763
Residues A, B, C and D E760, V349,R350,V366
Mutation M Y640F
MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQT
AATAAQQGGQANPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEY
VQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGQFTTKVR
LLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPN
AWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFIS
KERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTP
TTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM
Have a look at the AlphaFold structure in UniProt. What does the pLDDT score tell you?
The pLDDT score is a per-residue metric that indicates the confidence of the prediction.
Residues with a pLDDT scores > 70 are expected to be modeled well. On the other hand, the
position of residues with scores below 50 should not be interpreted, and are expected to be
disordered regions.
Same.
Download the AlphaFold structure from UniProt in PDB-format.
Select the residue, then do (sele) -> L (label) -> b-factor. The pLDDT is now displayed for
each atom (each atom in the residue has the same pLDDT)
Using the commands above, you can select all positive and negative residues, and then color
them blue and red, respectively.
In the stick representation, and visualizing the polar contacts, you can see interactions with
three negatively charged residues, which stabilize the positively charged Arg in the core.
Note: Having colored all charged residues, you can now see how they generally tend to be at
the surface, as they are highly hydrophilic.
Is residue D hydrophobic or hydrophilic? Is it at the surface or in the core? Is this what you
would expect?
It is hydrophobic. It is in the core of the protein, as expected.
It is hydrophobic. It is in the core of the protein, as expected.
How many hydrogen bonds does residue D make?
Two hydrogen bonds.
One hydrogen bond.
Showing hydrogen bonds in Pymol:
AF-P0112-F1-mod->Action (A) -> find -> polar contacts -> within selection
Hydrogen bonds for the entire structure shown as yellow dashed lines.
Residue 78 forms two hydrogen bonds, both in the backbone, the sidechain forms no
hydrogen bonds.
Topic 4: Mutation
Does mutation M violate the hydrophobicity rule?
Yes.
No.
Does mutation M violate the secondary structure propensity?
Yes.
No.
Is Mutation M related to cancer? If so, in which tissue is it mostly distributed?
Yes, mostly in the skin.
Yes, hematopoietic and lymphoid.
Is mutation M in an active/binding site?
No, but it is very close to a GTP binding site.
No.
What is the Zvelebil score of mutation M?
7 out of 10.
9 out of 10.
What is the Blosum score of mutation M?
-2.
3.
FoldX gives a ΔΔG of -1.02 kcal/mol or -0.77 kcal/mol for this mutation, what does that
mean?
It means the mutation is stabilizing.
Same.
Provean determines that this variant is pathogenic. Does this correlate to the FoldX
classification? Assuming both are correct, how would you explain this?
No, Provean determines that this modification is pathogenic. While both Provean and FoldX
are used to analyze protein sequences, Provean specifically predicts clinical significance of
human variants based on sequences of diverse organisms across evolution, while FoldX is
primarily employed for studying protein stability and protein-protein interactions, yielding
different outcomes. This mutation does not seem to problematic for intrinsic structure, but
it is predicted clinically detrimental for some other reason. Perhaps it targets an active site
residue. Given that this mutation affects an oncogene, it may also be that this stabilizing
mutation makes it constitutively active somehow, driving tumorigenesis.
Same.